Skip to content

The Effect of Mannitol on the Serum Potassium During Craniotomy

The Effect of Mannitol on Intraoperative Serum Potassium in Patients Undergoing Craniotomy:an Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03161977
Enrollment
30
Registered
2017-05-22
Start date
2017-01-01
Completion date
2017-06-01
Last updated
2017-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperkalemia, Mannitol Adverse Reaction

Brief summary

This is an observational study designed to research the effect of mannitol on the concentration of intraoperative serum potassium in patients undergoing craniotomy, and to guide the safe use of mannitol during craniotomy.

Detailed description

Patients were assigned to receive 20% mannitol (1g/kg) solution administered intravenously 15-20 minutes at the time of drilling skull.The serum potassium was measured by arterial blood gas analysis before infusion (T0), infusion finished (T1), 15min (T2), 30min (T3), 60min (T4) and 120min (T5) after infusion.

Interventions

OTHERMannitol

Mannitol was intravenous infused within 15-20 mins when drilling skull

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age 18 to 70 * American Society of Anesthesiologists physical status I to II * liver and kidney function is normal * preoperative concentration of serum potassium was from 3.5 to 5.5 mmol/L

Exclusion criteria

* history or presence of congestive heart failure (New York Heart Association class III to IV) * history or presence of renal failure(diabetes insipidus, or syndrome of inappropriate antidiuretic hormone secretion) * intraoperative blood transfusion

Design outcomes

Primary

MeasureTime frameDescription
the concentration of serum potassiumtwo hours within infusioning mannitolmeasured by arterial blood gas analysis

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026